Surgery for Pancreatic Cancer after neoadjuvant treatment
Author:
Open Access
- 10 September 2018
- journal article
- review article
- Published by Wiley in Annals of Gastroenterological Surgery
- Vol. 2 (6) , 413-418
Abstract
Pancreatic ductal adenocarcinoma (PDAC) remains to be a therapeutic challenge as only 15%‐20% of all patients present with resectable tumor stages by the time of diagnosis. In the remaining patients, either local tumor extension or systemic spread are obstacles for a surgical therapy as the only chance for long‐term survival. With regard to local tumor extension, PDAC has been classified as resectable, borderline‐resectable (BR) or locally advanced (LA). While there is currently no evidence for neoadjuvant therapy in resectable PDAC, this issue remains controversial in BR‐PDAC. In the case of venous tumor involvement, guidelines mostly recommend upfront resection, when technically possible; whereas arterial involvement is regarded as an indication for chemotherapy or chemoradiotherapy first. Furthermore, in locally advanced PDAC, neoadjuvant treatment approaches have recently resulted in high rates of secondary resection, thus allowing “conversion” surgery in an otherwise palliative treatment situation. The present review gives an overview on the current literature of treatment concepts in these situations and additionally focuses of evaluation of resectability after neoadjuvant therapy as well as technical aspects in this specific situation.Keywords
This publication has 40 references indexed in Scilit:
- Multimodality imaging of pancreatic ductal adenocarcinoma: a review of the literatureHPB, 2012
- Arterial Resection During Pancreatectomy for Pancreatic CancerAnnals of Surgery, 2011
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic CancerNew England Journal of Medicine, 2011
- Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection PercentagesPLOS Medicine, 2010
- The “Artery First” Approach for Resection of Pancreatic Head CancerJournal of the American College of Surgeons, 2010
- Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus StatementAnnals of Surgical Oncology, 2009
- Long-Term Survival After Multidisciplinary Management of Resected Pancreatic AdenocarcinomaAnnals of Surgical Oncology, 2009
- Survival After Pancreatectomy With Major Arterial Resection and ReconstructionAnnals of Surgical Oncology, 2008
- Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinomaThe American Journal of Surgery, 2008
- Resection of the Celiac Axis for Invasive Pancreatic CancerJournal of Gastrointestinal Surgery, 2005